{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:13:59Z","timestamp":1761513239245,"version":"build-2065373602"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.3816\/cbc.2007.s.003","type":"journal-article","created":{"date-parts":[[2008,9,11]],"date-time":"2008-09-11T21:04:54Z","timestamp":1221167094000},"page":"S21-S28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"S1","title":["Strategies for the Prevention of Treatment-Related Bone Loss in Women Receiving Adjuvant Hormonal Therapy"],"prefix":"10.3816","volume":"7","author":[{"given":"Hope S.","family":"Rugo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CBC.2007.s.003_bib1","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1359\/jbmr.1999.14.7.1217","article-title":"Hormone replacement therapy prevents osteoclastic hyperactivity: a histomorphometric study in early postmenopausal women","volume":"14","author":"Eriksen","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.3816\/CBC.2007.s.003_bib2","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/nm1096-1132","article-title":"Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta","volume":"2","author":"Hughes","year":"1996","journal-title":"Nat Med"},{"key":"10.3816\/CBC.2007.s.003_bib3","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1172\/JCI1039","article-title":"Loss of estrogen upregulates osteoblastogenesis in the murine bone marrow. Evidence for autonomy from factors released during bone resorption","volume":"101","author":"Jilka","year":"1998","journal-title":"J Clin Invest"},{"key":"10.3816\/CBC.2007.s.003_bib4","first-page":"719","article-title":"Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity","volume":"104","author":"Kousteni","year":"2001","journal-title":"Cell"},{"key":"10.3816\/CBC.2007.s.003_bib5","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S1470-2045(06)70948-2","article-title":"Effectiveness of switching from adjuvant tamoxifen to anastrozole in postmenopausal women with hormone-sensitive early breast cancer: a meta-analysis","volume":"7","author":"Jonat","year":"2006","journal-title":"Lancet Oncol"},{"issue":"18 suppl","key":"10.3816\/CBC.2007.s.003_bib6","first-page":"36s","article-title":"Early switch with aromatase inhibitors as adjuvant hormonal therapy for postmenopausal breast cancer: pooled-analysis of 8,794 patients","volume":"24","author":"Ciccarese","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.3816\/CBC.2007.s.003_bib7","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/jnci\/dji250","article-title":"Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17","volume":"97","author":"Goss","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.3816\/CBC.2007.s.003_bib8","series-title":"Osteoporosis","first-page":"22","article-title":"Pathogenesis of osteoporosis and fracture","author":"Kanis","year":"1997"},{"issue":"suppl 1","key":"10.3816\/CBC.2007.s.003_bib9","first-page":"S165","article-title":"Effect of anastrozole on bone density and bone turnover: results of the \u2018Arimidex\u2019 (anastrozole), Tamoxifen, Alone or in Combination (ATAC) study","volume":"17","author":"Eastell","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.3816\/CBC.2007.s.003_bib10","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1200\/JCO.2001.19.14.3306","article-title":"Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with earlystage breast cancer","volume":"19","author":"Shapiro","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.3816\/CBC.2007.s.003_bib11","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1200\/JCO.2005.02.7102","article-title":"Zoledronic acid prevents cancer-treatment induced bone loss in premenopausal women receiving adjuvant endrocrine therapy for hormone-responsive breast cancer: a report from the Austrian Breast and Colorectal Cancer Study Group","volume":"25","author":"Gnant","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.3816\/CBC.2007.s.003_bib12","first-page":"17","article-title":"Bone metabolism: newer perspectives","volume":"19","author":"Ghani","year":"1997","journal-title":"Malays J Pathol"},{"key":"10.3816\/CBC.2007.s.003_bib13","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/jcb.240550303","article-title":"Osteonal and hemi-osteonal remodeling: the spatial and temporal framework for signal traffic in adult human bone","volume":"55","author":"Parfitt","year":"1994","journal-title":"J Cell Biochem"},{"key":"10.3816\/CBC.2007.s.003_bib14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s007740300021","article-title":"Signal transduction pathways regulating osteoclast differentiation and function","volume":"21","author":"Tanaka","year":"2003","journal-title":"J Bone Miner Metab"},{"key":"10.3816\/CBC.2007.s.003_bib15","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJM199502023320506","article-title":"Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis","volume":"332","author":"Manolagas","year":"1995","journal-title":"N Engl J Med"},{"key":"10.3816\/CBC.2007.s.003_bib16","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1172\/JCI200317215","article-title":"Role of RANK ligand in mediating increased bone resorption in early postmenopausal women","volume":"111","author":"Eghbali-Fatourechi","year":"2003","journal-title":"J Clin Invest"},{"key":"10.3816\/CBC.2007.s.003_bib17","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1210\/endo.142.12.8536","article-title":"Minireview: the OPG\/RANKL\/RANK system","volume":"142","author":"Khosla","year":"2001","journal-title":"Endocrinology"},{"key":"10.3816\/CBC.2007.s.003_bib18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/(SICI)1098-2795(199701)46:1<75::AID-MRD12>3.0.CO;2-2","article-title":"Role of CSF-1 in bone and bone marrow development","volume":"46","author":"Cecchini","year":"1997","journal-title":"Mol Reprod Dev"},{"key":"10.3816\/CBC.2007.s.003_bib19","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1172\/JCI28550","article-title":"Estrogen deficiency and bone loss: an inflammatory tale","volume":"116","author":"Weitzmann","year":"2006","journal-title":"J Clin Invest"},{"key":"10.3816\/CBC.2007.s.003_bib20","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1172\/JCI0215687","article-title":"Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency","volume":"110","author":"Weitzmann","year":"2002","journal-title":"J Clin Invest"},{"key":"10.3816\/CBC.2007.s.003_bib21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1126\/science.3164526","article-title":"Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells","volume":"241","author":"Komm","year":"1988","journal-title":"Science"},{"key":"10.3816\/CBC.2007.s.003_bib22","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1359\/jbmr.1998.13.8.1243","article-title":"The role of estrogen in the control of rat osteocyte apoptosis","volume":"13","author":"Tomkinson","year":"1998","journal-title":"J Bone Miner Res"},{"key":"10.3816\/CBC.2007.s.003_bib23","doi-asserted-by":"crossref","first-page":"6613","DOI":"10.1073\/pnas.88.15.6613","article-title":"Avian osteoclasts as estrogen target cells","volume":"88","author":"Oursler","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3816\/CBC.2007.s.003_bib24","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.0105-2896.2005.00324.x","article-title":"The role of T lymphocytes in bone metabolism","volume":"208","author":"Weitzmann","year":"2005","journal-title":"Immunol Rev"},{"key":"10.3816\/CBC.2007.s.003_bib25","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1172\/JCI11653","article-title":"Attenuation of the selfrenewal of transit-amplifying osteoblast progenitors in the murine bone marrow by 17 beta-estradiol","volume":"107","author":"Di Gregorio","year":"2001","journal-title":"J Clin Invest"},{"key":"10.3816\/CBC.2007.s.003_bib26","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/jbmr.5650110802","article-title":"Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis","volume":"11","author":"Pacifici","year":"1996","journal-title":"J Bone Miner Res"},{"year":"1994","series-title":"World Health Organization technical report: assessment of fracture risk and its applications to screening for postmenopausal osteoporosis-report of a WHO study group","author":"WHO","key":"10.3816\/CBC.2007.s.003_bib27"},{"key":"10.3816\/CBC.2007.s.003_bib28","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1200\/JCO.2003.08.017","article-title":"American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer","volume":"21","author":"Hillner","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.3816\/CBC.2007.s.003_bib29","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(04)17666-6","article-title":"Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer","volume":"365","author":"Howell","year":"2005","journal-title":"Lancet"},{"issue":"16 suppl","key":"10.3816\/CBC.2007.s.003_bib30","first-page":"10s","article-title":"Switching to anastrozole (ANA) vs continued tamoxifen (TAM) treatment of early breast cancer (EBC). Updated results of the Italian Tamoxifen Anastrozole (ITA) trial","volume":"23","author":"Boccardo","year":"2005","journal-title":"J Clin Oncol"},{"issue":"18 suppl","key":"10.3816\/CBC.2007.s.003_bib31","first-page":"14s","article-title":"Mortality benefit of switching to an aromatase inhibitor in early breast carcinoma: pooled analysis of two consecutive trials","volume":"24","author":"Boccardo","year":"2006","journal-title":"J Clin Oncol"},{"issue":"18 suppl","key":"10.3816\/CBC.2007.s.003_bib32","first-page":"9s","article-title":"First mature analysis of the Intergroup Exemestane Study (IES)","volume":"24","author":"Coombes","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.3816\/CBC.2007.s.003_bib33","article-title":"The benefits of sequencing adjuvant tamoxifen and anastrozole in postmenopausal women with hormoneresponsive early breast cancer: 5 year-analysis of ABCSG Trial 8","volume":"94","author":"Jakesz","year":"2005","journal-title":"Breast Cancer Res Treat"},{"key":"10.3816\/CBC.2007.s.003_bib34","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0140-6736(05)67059-6","article-title":"Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial","volume":"366","author":"Jakesz","year":"2005","journal-title":"Lancet"},{"issue":"18 suppl","key":"10.3816\/CBC.2007.s.003_bib35","first-page":"14s","article-title":"Survival benefit of switching to anastrozole after 2 years' treatment with tamoxifen versus continued tamoxifen therapy: the ARNO 95 study","volume":"24","author":"Kaufmann","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.3816\/CBC.2007.s.003_bib36","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1200\/JCO.2006.08.8617","article-title":"Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98","volume":"25","author":"Coates","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.3816\/CBC.2007.s.003_bib37","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1200\/JCO.2005.09.121","article-title":"American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004","volume":"23","author":"Winer","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.3816\/CBC.2007.s.003_bib38","doi-asserted-by":"crossref","first-page":"24","DOI":"10.5694\/j.1326-5377.2005.tb06882.x","article-title":"The aromatase inhibitors in early breast cancer: who, when, and why?","volume":"183","author":"Nordman","year":"2005","journal-title":"Med J Aust"},{"key":"10.3816\/CBC.2007.s.003_bib39","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3816\/CBC.2005.n.006","article-title":"Aromatase inhibitors for the treatment and prevention of breast cancer","volume":"6","author":"Kalidas","year":"2005","journal-title":"Clin Breast Cancer"},{"key":"10.3816\/CBC.2007.s.003_bib40","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1200\/JCO.2001.19.3.881","article-title":"Aromatase inhibitors in the treatment and prevention of breast cancer","volume":"19","author":"Goss","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.3816\/CBC.2007.s.003_bib41","first-page":"109","article-title":"Osteoblast cells (MG-63 and HOS) have aromatase and 5 alpha-reductase activities","volume":"39","author":"Shimodaira","year":"1996","journal-title":"Biochem Mol Biol Int"},{"key":"10.3816\/CBC.2007.s.003_bib42","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1200\/JCO.1994.12.5.992","article-title":"Tamoxifen and bone metabolism in postmenopausal low-risk breast cancer patients: a randomized study","volume":"12","author":"Kristensen","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.3816\/CBC.2007.s.003_bib43","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1056\/NEJM199203263261302","article-title":"Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer","volume":"326","author":"Love","year":"1992","journal-title":"N Engl J Med"},{"key":"10.3816\/CBC.2007.s.003_bib44","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1200\/JCO.2005.05.4882","article-title":"Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17","volume":"24","author":"Perez","year":"2006","journal-title":"J Clin Oncol"},{"issue":"18 suppl","key":"10.3816\/CBC.2007.s.003_bib45","first-page":"5s","article-title":"Effect of anastrozole on bone mineral density: 5-year results from the \u2018Arimidex\u2019, Tamoxifen, Alone or in Combination (ATAC) trial","volume":"24","author":"Coleman","year":"2006","journal-title":"J Clin Oncol"},{"issue":"18 suppl","key":"10.3816\/CBC.2007.s.003_bib46","first-page":"18s","article-title":"Analysis of fracture risk factors from the \u2018Arimidex\u2019, Tamoxifen, Alone or in Combination (ATAC) trial: 5-year data","volume":"24","author":"Howell","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.3816\/CBC.2007.s.003_bib47","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1056\/NEJMoa052258","article-title":"A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer","volume":"353","author":"Thurlimann","year":"2005","journal-title":"N Engl J Med"},{"key":"10.3816\/CBC.2007.s.003_bib48","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1470-2045(07)70003-7","article-title":"Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study","volume":"8","author":"Coleman","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.3816\/CBC.2007.s.003_bib49","first-page":"ix93","article-title":"Five years of continuous letrozole versus adjuvant endocrine therapy for postmenopausal women with endocrine-responsive breast cancer: further analyses and update of of BIG 1-98","volume":"17","author":"Coates","year":"2006","journal-title":"Ann Oncol"},{"key":"10.3816\/CBC.2007.s.003_bib50","doi-asserted-by":"crossref","first-page":"5126","DOI":"10.1200\/JCO.2005.07.097","article-title":"Effects of exemestane administered for 2 years versus placebo on bone mineral density, bone biomarkers, and plasma lipids in patients with surgically resected early breast cancer","volume":"23","author":"Lonning","year":"2005","journal-title":"J Clin Oncol"},{"issue":"18 suppl","key":"10.3816\/CBC.2007.s.003_bib51","first-page":"9s","volume":"24","author":"Coombes","year":"2006","journal-title":"J Clin Oncol"},{"issue":"16 suppl","key":"10.3816\/CBC.2007.s.003_bib52","first-page":"11s","article-title":"Changes in bone metabolism after 2 years' treatment with exemestane (E) in postmenopausal women with early breast cancer (EBC) at low risk: follow-up (FU) results of a randomized placebo-controlled study","volume":"23","author":"Lonning","year":"2005","journal-title":"J Clin Oncol"},{"issue":"18 suppl","key":"10.3816\/CBC.2007.s.003_bib53","first-page":"17s","article-title":"Risk of cancer treatment-related osteoporosis and fractures among women with breast cancer receiving aromatase inhibitors","volume":"24","author":"Mincey","year":"2006","journal-title":"J Clin Oncol"},{"issue":"suppl 1","key":"10.3816\/CBC.2007.s.003_bib54","first-page":"S76","article-title":"A randomized, placebo-controlled explorative study to investigate the effect of low estrogen plasma levels on markers or bone turnover in healthy post-menopausal women during the 12-week treatment with exemestane or letrozole","volume":"76","author":"Goss","year":"2002","journal-title":"Breast Cancer Res Treat"},{"key":"10.3816\/CBC.2007.s.003_bib55","first-page":"614","article-title":"Effects of the aromatase inhibitor letrozole on normal breast epithelial cell proliferation and metabolic indices in postmenopausal women: a pilot study for breast cancer prevention","volume":"11","author":"Harper-Wynne","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.3816\/CBC.2007.s.003_bib56","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1359\/jbmr.2002.17.1.172","article-title":"Role of low levels of endogenous estrogen in regulation of bone resorption in late postmenopausal women","volume":"17","author":"Heshmati","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.3816\/CBC.2007.s.003_bib57","first-page":"734","article-title":"Effects of steroidal and nonsteroidal aromatase inhibitors (AIs) on markers of bone turnover and lipid metabolism in healthy volunteers","volume":"23","author":"Subar","year":"2004","journal-title":"Proc Am Soc Clin Oncol"},{"issue":"18 suppl","key":"10.3816\/CBC.2007.s.003_bib58","first-page":"582s","article-title":"The Head to Head trial: letrozole vs anastrozole as adjuvant treatment of postmenopausal patients with node positive breast cancer","volume":"24","author":"De Boer","year":"2006","journal-title":"J Clin Oncol"},{"author":"IBCIS","key":"10.3816\/CBC.2007.s.003_bib59"},{"key":"10.3816\/CBC.2007.s.003_bib61","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1200\/JCO.2001.19.1.10","article-title":"Adjuvant clodronate treatment does not reduce the frequency of skeletal metastases in node-positive breast cancer patients: 5-year results of a randomized controlled trial","volume":"19","author":"Saarto","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.3816\/CBC.2007.s.003_bib62","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1200\/JCO.1997.15.3.955","article-title":"Bisphosphonate risedronate prevents bone loss in women with artificial menopause due to chemotherapy of breast cancer: a double-blind, placebo-controlled study","volume":"15","author":"Delmas","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.3816\/CBC.2007.s.003_bib63","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1200\/JCO.2005.05.3744","article-title":"Zoledronic acid inhibits adjuvant letrozole-induced bone loss in postmenopausal women with early breast cancer","volume":"25","author":"Brufsky","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.3816\/CBC.2007.s.003_bib64","unstructured":"Bundred N, Campbell I, Coleman R. Zoledronic acid in the prevention of cancer treatment-induced bone loss in postmenopausal women receiving letrozole as adjuvant therapy for early breast cancer (ZOFAST study). Presented at: 5th European Breast Cancer Conference; March 21-25, 2006; Nice, France. Abstract #12."},{"key":"10.3816\/CBC.2007.s.003_bib65","article-title":"An integrated analysis of zoledronic acid (ZA) for prevention of aromatase inhibitor associated bone loss (AIBL) in postmenopausal women (PMW) with early breast cancer (BCa) receiving adjuvant letrozole (LET)","volume":"100","author":"Brufsky","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"10.3816\/CBC.2007.s.003_bib66","article-title":"The Sabre study: effects of risedronate on bone mineral density and bone metabolism in postmenopausal women using anastrozole as adjuvant therapy for hormone receptor-positive early breast cancer -first results","volume":"100","author":"Van Poznak","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"10.3816\/CBC.2007.s.003_bib67","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jsbmb.2005.04.023","article-title":"Clinical use of aromatase inhibitors (AI) in premenopausal women","volume":"95","author":"de Ziegler","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.3816\/CBC.2007.s.003_bib68","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1200\/JCO.2004.08.148","article-title":"Bone mineral density among premenopausal women with early breast cancer in a randomized trial of adjuvant endocrine therapy","volume":"22","author":"Sverrisdottir","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.3816\/CBC.2007.s.003_bib69","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1359\/JBMR.050304","article-title":"Predictive value of BMD for hip and other fractures","volume":"20","author":"Johnell","year":"2005","journal-title":"J Bone Miner Res"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820911708011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820911708011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:10:49Z","timestamp":1761513049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820911708011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":68,"alternative-id":["S1526820911708011"],"URL":"https:\/\/doi.org\/10.3816\/cbc.2007.s.003","relation":{},"ISSN":["1526-8209"],"issn-type":[{"type":"print","value":"1526-8209"}],"subject":[],"published":{"date-parts":[[2007,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Strategies for the Prevention of Treatment-Related Bone Loss in Women Receiving Adjuvant Hormonal Therapy","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3816\/CBC.2007.s.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}